Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Apr 1, 2019 | Arrakis Therapeutics | $75.0M Series B | Jakob Loven | 5AM Ventures, Access Biotechnology, Canaan Partners, Connecticut Innovations, Endeavor Venture Funds, HealthQuest Capital, Nextech Invest, OrbiMed, RA Capital, venBio, Advent Life Sciences, Alexandria Venture Investments, Canaan Partners, Celgene, Google Ventures, HBM Healthcare Investments, Omega Funds, Osage University Partners, WuXi AppTec |